High Growth Tech Stocks In The UK Featuring Keywords Studios And Two More
In This Article:
The UK market has faced challenges recently, with the FTSE 100 index experiencing a decline following weak trade data from China, highlighting concerns over global economic recovery and its impact on commodity-linked companies. In this environment, high-growth tech stocks such as Keywords Studios offer potential opportunities for investors seeking resilience and innovation amidst broader market uncertainties.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
| STV Group | 13.15% | 46.78% | ★★★★★☆ |
| Altitude Group | 23.46% | 27.56% | ★★★★★☆ |
| Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
| LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
| Redcentric | 4.89% | 63.79% | ★★★★★☆ |
| Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
| Beeks Financial Cloud Group | 22.12% | 36.94% | ★★★★★☆ |
| Oxford Biomedica | 21.00% | 98.44% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 49 stocks from our UK High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Keywords Studios
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Keywords Studios plc offers creative and technical services to the video game industry globally, with a market capitalization of ￡1.97 billion.
Operations: Keywords Studios generates revenue through three main segments: Create (€365.56 million), Engage (€180.43 million), and Globalize (€261.61 million).
Despite a challenging backdrop, Keywords Studios is poised to capitalize on robust industry trends with its forecasted revenue growth of 10.2% per year, outpacing the UK market's 3.5%. The company's strategic investments in research and development are substantial, aiming to fuel innovation and maintain competitive advantage in the gaming and tech services sectors. Recent events underscore this direction; notably, Keywords Studios was recently acquired for ￡2 billion by a consortium led by EQT Private Capital Asia and CPP Investments, reflecting confidence in its future trajectory. This acquisition not only values Keywords at approximately 15.9 times its adjusted EBITDA but also sets a strong foundation for future growth under new ownership—expected to be finalized in Q4 2024—with an emphasis on expanding its service offerings and market reach.
-
Click to explore a detailed breakdown of our findings in Keywords Studios' health report.
-
Review our historical performance report to gain insights into Keywords Studios''s past performance.
Oxford Biomedica
Simply Wall St Growth Rating: ★★★★★☆
Overview: Oxford Biomedica plc is a contract development and manufacturing organization specializing in delivering therapies globally, with a market capitalization of ￡448.83 million.